Integrated Wealth Counsel’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$217K Hold
3,705
0.47% 29
2016
Q3
$200K Hold
3,705
0.42% 27
2016
Q2
$273K Hold
3,705
0.63% 21
2016
Q1
$237K Sell
3,705
-4,135
-53% -$261K 0.54% 22
2015
Q4
$502K Buy
7,840
+3,920
+100% +$259K 0.8% 16
2015
Q3
$232K Hold
3,920
0.39% 22
2015
Q2
$261K Hold
3,920
0.36% 22
2015
Q1
$253K Hold
3,920
0.32% 24
2014
Q4
$231K Hold
3,920
0.28% 24
2014
Q3
$201K Sell
3,920
-215
-5% -$10.7K 0.21% 25
2014
Q2
$201K Hold
4,135
0.16% 41
2014
Q1
$215K Sell
4,135
-365
-8% -$19.4K 0.17% 53
2013
Q4
$239K Hold
4,500
0.18% 54
2013
Q3
$208K Hold
4,500
0.15% 58
2013
Q2
$201K Buy
+4,500
New +$195K 0.14% 61

Other funds holding BMY

Integrated Wealth Counsel's BMY Position: Q4 2016 in Review

Integrated Wealth Counsel held its Bristol-Myers Squibb (BMY) position steady in Q4 2016 at 3,705 shares worth $217K. The position accounts for 0.47% of the portfolio, ranked #29.

Integrated Wealth Counsel first reported a position in BMY in Q2 2013 and has held it in 15 quarters since. The position peaked at $502K in Q4 2015. 1,601 funds tracked by Wall St. Rank hold BMY as of Q4 2016.

  • Integrated Wealth Counsel held 3,705 shares of Bristol-Myers Squibb worth $217K as of Q4 2016.
  • Integrated Wealth Counsel left its Bristol-Myers Squibb share count unchanged in Q4 2016.
  • Bristol-Myers Squibb made up 0.47% of Integrated Wealth Counsel's portfolio in Q4 2016, its #29 holding.
  • Integrated Wealth Counsel first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 15 quarters since.
  • Integrated Wealth Counsel's Bristol-Myers Squibb position peaked at $502K in Q4 2015.
  • 1,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2016.

Based on Integrated Wealth Counsel's 13F filing for Q4 2016, filed 6 Feb 2017.